eF-site ID 1saf_13-ABCD
PDB Code 1saf
Model 13
Chain A, B, C, D

click to enlarge
Title HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAD STRUCTURES)
Classification ANTI-ONCOGENE
Compound TUMOR SUPPRESSOR P53
Source ORGANISM_COMMON: human; ORGANISM_SCIENTIFIC: Homo sapiens;
Sequence A:  KKKPLDGEYFTLQIRGRERFEMFRELNEALELKDAQAGKE
PG
B:  KKKPLDGEYFTLQIRGRERFEMFRELNEALELKDAQAGKE
PG
C:  KKKPLDGEYFTLQIRGRERFEMFRELNEALELKDAQAGKE
PG
D:  KKKPLDGEYFTLQIRGRERFEMFRELNEALELKDAQAGKE
PG
Description (1)  TUMOR SUPPRESSOR P53


Functional site

1) chain A
residue 321
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0000250|UniProtKB:P02340
source Swiss-Prot : SWS_FT_FI1

2) chain B
residue 321
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0000250|UniProtKB:P02340
source Swiss-Prot : SWS_FT_FI1

3) chain C
residue 321
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0000250|UniProtKB:P02340
source Swiss-Prot : SWS_FT_FI1

4) chain D
residue 321
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0000250|UniProtKB:P02340
source Swiss-Prot : SWS_FT_FI1

5) chain A
residue 333
type MOD_RES
sequence R
description Omega-N-methylarginine; by PRMT5 => ECO:0000269|PubMed:19011621
source Swiss-Prot : SWS_FT_FI2

6) chain B
residue 333
type MOD_RES
sequence R
description Omega-N-methylarginine; by PRMT5 => ECO:0000269|PubMed:19011621
source Swiss-Prot : SWS_FT_FI2

7) chain C
residue 333
type MOD_RES
sequence R
description Omega-N-methylarginine; by PRMT5 => ECO:0000269|PubMed:19011621
source Swiss-Prot : SWS_FT_FI2

8) chain D
residue 333
type MOD_RES
sequence R
description Omega-N-methylarginine; by PRMT5 => ECO:0000269|PubMed:19011621
source Swiss-Prot : SWS_FT_FI2

9) chain A
residue 335
type MOD_RES
sequence R
description Symmetric dimethylarginine; by PRMT5 => ECO:0000269|PubMed:19011621
source Swiss-Prot : SWS_FT_FI3

10) chain A
residue 337
type MOD_RES
sequence R
description Symmetric dimethylarginine; by PRMT5 => ECO:0000269|PubMed:19011621
source Swiss-Prot : SWS_FT_FI3

11) chain B
residue 335
type MOD_RES
sequence R
description Symmetric dimethylarginine; by PRMT5 => ECO:0000269|PubMed:19011621
source Swiss-Prot : SWS_FT_FI3

12) chain B
residue 337
type MOD_RES
sequence R
description Symmetric dimethylarginine; by PRMT5 => ECO:0000269|PubMed:19011621
source Swiss-Prot : SWS_FT_FI3

13) chain C
residue 335
type MOD_RES
sequence R
description Symmetric dimethylarginine; by PRMT5 => ECO:0000269|PubMed:19011621
source Swiss-Prot : SWS_FT_FI3

14) chain C
residue 337
type MOD_RES
sequence R
description Symmetric dimethylarginine; by PRMT5 => ECO:0000269|PubMed:19011621
source Swiss-Prot : SWS_FT_FI3

15) chain D
residue 335
type MOD_RES
sequence R
description Symmetric dimethylarginine; by PRMT5 => ECO:0000269|PubMed:19011621
source Swiss-Prot : SWS_FT_FI3

16) chain D
residue 337
type MOD_RES
sequence R
description Symmetric dimethylarginine; by PRMT5 => ECO:0000269|PubMed:19011621
source Swiss-Prot : SWS_FT_FI3


Display surface

Download
Links